A method is presented for the generation of parametric images of radioligand-receptor binding using PET. The method is based on a simplified reference region compartmental model, which requires no arterial blood sampling, and gives parametric images of both the binding potential of the radioligand and its local rate of delivery relative to the reference region. 
INTRODUCTION
This paper considers the evolution of a reference region model for the quantification of radioligandreceptor binding in the brain using positron emission tomography (PET) and shows how this development allows for a robust voxel by voxel implementation yielding parametric images of binding potential (BP; Mintun et al., 1984) , and the local rate of delivery of the radioligand relative to the reference region (R I ).
Parametric imaging of compartmental models in PET is often compromised by two factors. First, a high degree of parameterization in the model can lead to numerically unidentifiable parameter estimates, and second, optimization using conventional nonlinear least squares methods is both time-consuming and prone to local minima. These issues, which are particularly important at the voxel level, are addressed in this paper.
The present work employs a simplified reference region model involving only three parameters: BP, R I , and k 2 (the effective efflux rate constant from the tissue) and introduces a basis function approach, including parameter bounds, to its solution. An algorithm enabling a fast and robust implementation of this model on a voxel by voxel basis is presented and the method is applied to three PET ligands: [ 11 C]raclopride (a marker of the D2 receptor) and [ 11 C]SCH 23390 (a marker of the D1 receptor) in humans and [ 11 C]CFT (a marker of the dopamine transporter) in rats.
THEORY

Background
The reference region model described by Blomqvist et al. (1989) and by Cunningham et al. (1991) relies on the existence of a tissue region with a negligible concentration of specific (saturable) binding sites. Under tracer conditions, formulation of this model involves six rate constants: K 1 , k 2 , K Ј 1 , kЈ 2 , describing the exchange of tracer between plasma and free (plus nonspecifically bound) ligand compartments in the region of interest and the reference region respectively, and k 3 , k 4 , describing the exchange of tracer between the free compartment and a specifically bound ligand compartment in the region of interest. By using the reference region to describe the kinetics of the free ligand, and assuming that the degree of nonspecific binding is the same in both regions, the kinetics of the ligand in tissue regions of interest displaying specific binding may then be described as a function of the reference region. This removes the need for a metabolite-corrected plasma input function. Under tracer conditions this formulation has five identifiable parameters groupings: (Cunningham et al., 1991; Gunn, 1996) . Under the further assumption that the volume of distribution of the free compartment is the same in both regions (i.e., K 1 /k 2 ϭ K Ј 1 /kЈ 2 ) the number of parameters required is reduced to four: R I , k 2 , k 3 , k 4 (Cunningham et al., 1991; Hume et al., 1992) . This formulation has been validated for [ 11 C]diprenorphine in the rat by comparison with data obtained in vitro (Cunningham et al., 1991) and for [ 11 C]raclopride in humans by compari-son with the equivalent plasma input model . In these cases there is a finite rate of exchange between the free and the specifically bound compartments. introduced an additional simplification to the model which can be applied to ligands for which the exchange between the free and the specifically bound compartments is sufficiently rapid. In these cases the tissue region of interest may be approximated by a single compartment. This reduces the number of parameters required to three (R I , k 2 , BP), where BP is the binding potential (c.f. Mintun et al., 1984) . Here we define
, where B max is the total concentration of specific binding sites, K D Tracer is the equilibrium disassociation constant of the radioligand, f 2 is the ''free fraction'' of the unbound radioligand in the tissue, and F i and K D i are the concentration and equilibrium disassociation constants of i competing endogenous ligands.
The simplified reference region model has the following operational equation,
where C R (t) is the concentration time course in the reference region, C T (t) is the concentration time course in the tissue region of interest, k 2 is the (effective) efflux rate constant from the tissue, R I is the ratio of the delivery in the tissue region of interest compared to that in the reference region (ratio of influx), and is the physical decay constant of the isotope. ᮏ is the convolution operator. Note that the above formulation refers to nondecay corrected data (see later).
This model has been validated and applied successfully on a region of interest (ROI) basis . However, application of this model at the voxel level using a conventional nonlinear least squares approach to parameter estimation is slow and sensitive to noise. This problem is addressed in the present paper as follows.
Formulation
The simplified reference region model may be rewritten as,
This equation is linear in 1 and 2 . Hence for fixed values of 3 , 1 and 2 can be estimated using standard linear least squares. The nonlinear term can be dealt with by choosing a discrete spectrum of parameter values for 3 (see below) and forming the corresponding basis functions;
2) can then be transformed into a linear equation for each basis function,
Equation (4) 
where 3 min Յ k 2 min /(1 ϩ BP max ) ϩ and 3 max Ն k 2 max ϩ . For the ligands considered in this paper 100 discrete values for 3 were found to be sufficient with 3 min ϭ 0.001s Ϫ1 and 3 max ϭ 0.01s Ϫ1 .
Algorithm
A fast algorithm for the basis function method (BFM) is obtained by performing as many of the calculations as possible before considering the individual voxel time courses. Weighted least squares solutions are obtained by employing a QR decomposition of the reference region with each of the basis functions separately. The algorithm is summarized below in pseudo-code; Initially C R (t ) measured reference region time course
basis functions, i ϭ 1, . . . , 100
w ϭ (frame duration) 2 total counts in frame weights W ϭ diag(ͱw) weighting matrix For i ϭ 1:100
where m ϭ R\Q T is the solution in the least squares sense to the overdetermined system of equations Rm ϭ Q T . For each voxel
where n is the number of frames For i ϭ 1:100
METHODS
Simulations
Monte Carlo simulations were carried out in order to compare the behavior of the BFM with a conventional nonlinear least squares method (NLM) in the presence of noise. Perfect reference and tissue data were generated with the model, using a metabolite-corrected plasma input function obtained from a human [ 11 C]-raclopride study with continuous blood sampling, discrete measures of plasma and whole blood activity, discrete plasma metabolites assays as described by , and by choosing parameter values for both a high and low binding region (R I ϭ 1.2, k 2 ϭ 0.0024s Ϫ1 , BP ϭ 2, and R I ϭ 1.2, k 2 ϭ 0.0024s Ϫ1 , BP ϭ 0.2, respectively). Noisy data were then obtained by adding normally distributed noise to the perfect data. The simulations were performed for a typical study protocol of 17 frames over a period of 1 h (1 ϫ 15, 1 ϫ 5, 1 ϫ 10, 1 ϫ 30, 4 ϫ 60, 3 ϫ 300, 2 ϫ 600, 4 ϫ 300 s). A lower level of noise was added to the reference data than the tissue data (noise in tissue ϭ 20 ϫ noise in reference region) to simulate a situation where the reference data obtained from a larger region of interest is smoother than the voxel data. The normally distributed noise was scaled such that 1 standard deviation corresponded to the maximum count in each simulated curve (i.e., 1 corresponds to a very high noise level). 1000 realizations were produced for all the simulations at each different noise level. Data were analyzed using BFM as described above. For NLM a simplex method was employed to minimize the weighted residual sums of squares (Nelder and Mead, 1965) .
The sensitivity of the estimated binding potential to the presence of specific binding in the reference region was also investigated using noiseless simulated data. These simulated results were compared with an explicit algebraic equation derived from a consideration of the ratio of the expected distribution volumes at equilibrium.
where BP Reference and BP Tissue are the true binding potentials of the ligand in the reference and target tissues, respectively. BP Apparent would be the binding potential estimated in the target tissue under the assumption that BP Reference is zero.
Human Studies
[ 11 C]Raclopride. Data were taken from an ongoing study (Dr P. Grasby, MRC Cyclotron Unit) for which ARSAC and local hospital approved ethics permission had been obtained. Four normal volunteers were scanned for 1 h after intravenous administration of [ 11 C]raclopride (Injected activity: 9.62, 9.28, 9.65, 9.73 mCi) using an ECAT 953B PET camera (CTI/Siemens, Knoxville, TN) which has been previously characterized (Spinks et al., 1992) . Dynamic data were acquired in 3D mode and 17 frames (1 ϫ 15, 1 ϫ 5, 1 ϫ 10, 1 ϫ 30, 4 ϫ 60, 3 ϫ 300, 2 ϫ 600, 4 ϫ 300 s) were collected. A convolution subtraction method was used for scatter correction (Bailey and Meikle, 1994 ) and a 3D reconstructed image was obtained using a reprojection algorithm (Kinahan and Rogers, 1989) , which included a calculated attenuation correction. An ROI template was defined on an integral image (Sawle et al., 1990; Bench et al., 1993) and applied to the dynamic images to produce time radioactivity curves corresponding anatomically to cerebellum (reference region), caudate, putamen, left caudate, right caudate, left anterior putamen, right anterior putamen, left mid putamen, right mid putamen, left posterior putamen, right posterior putamen, frontal cortex, occipital cortex, and thalamus.
[ 11 C]SCH 23390. Data were taken from an ongoing study (Dr. T. Andrews, MRC Cyclotron Unit) for which ARSAC and local hospital approved ethics permission had been obtained. A single [ 11 C]SCH 23390 scan was acquired using an identical protocol to the [ 11 C]raclopride scan described above (Injected activity: 10.64 mCi). of 11.5 cm and an axial field of view of 5 cm and its physical characteristics have been described previously . Dynamic data were acquired in 3D mode (Bloomfield et al., 1997) and 21 frames of data (3 ϫ 5, 3 ϫ 15, 4 ϫ 60, 11 ϫ 300 s) were collected.
Rat Studies
[ 11 C]CFT was administered as a bolus via a catheter previously implanted in a lateral vein of the tail (range 196-365 µCi). Different specific activities (equivalent to cold doses in the range 0.30-8178 nmol.(kg body weight) Ϫ1 ) were injected so as to give a range of binding potential values. The dynamic images were reconstructed using filtered back projection (Kinahan and Rogers, 1989 ) and these images were subsequently interpolated to give cubic voxels, using Analyze software (Robb and Hanson, 1991 ). An ROI template (Myers et al., 1996) was defined on an integral image and applied to the dynamic images to produce time radioactivity curves corresponding anatomically to the and on a voxel by voxel basis using the BFM described above.
RESULTS
The present method (BFM) was developed in order to implement the simplified reference region model at the voxel level. This model has previously been validated using time activity data derived from large ROIs, with correspondingly less noise, employing conventional nonlinear least squares for parameter estimation (NLM). It will be seen later that NLM cannot be applied at the voxel level. In order to compare BFM with NLM, studies were therefore carried out using both simulated and real data. A comparison based on simulated human [ 11 C]raclopride studies is presented first.
The performance of the two methods as a function of noise in the simulated data is illustrated in Fig. 1 . By considering the simulations for a high binding area (Fig. 1a) this shows that for low noise levels (up to 0.1) there was essentially no difference between the two methods in terms of bias or variance. In this case the estimates obtained by the NLM for 3 all lie within the range of values corresponding to the basis functions chosen for the BFM. However, when the noise level exceeded 0.1, the NLM was unstable and gave unreasonably large values for BP. This problem is avoided with the BFM due to the parameter bounds introduced on the exponential term (see Theory). At these higher noise levels a corresponding bias becomes apparent in the BFM. However, the bias introduced is small even at high noise levels. When considering the simulations for the low binding area (Figure 1b ) the NLM was unable to find a solution, even for low noise levels. This can be explained by the fact that the parameter k 2 becomes numerically unidentifiable in this case. The BFM, however, is robust due to the inclusion of the parameter bounds. The variance in the BP parameter estimate is increased slightly and there is still no significant bias. The large variance in k 2 illustrates that this parameter is often numerically unidentifiable and that parameter bounds are essential.
When comparing the performance of the two methods on real data it was therefore necessary to apply the NLM to the average time activity curves derived from whole ROIs, whereas the BFM could be applied at the voxel level. The resultant voxel parameter estimates from the BFM were therefore averaged over the ROIs for comparison with NLM. The correspondence be- tween the two methods is illustrated for four [ 11 C]raclopride studies in humans in Figs. 2 and 3 and the values tabulated in Table 1 . These results show that the parametric images are well correlated with the previously validated estimates of BP and R I obtained for ROIs using NLM.
Figures 4 and 5, together with Table 2 give the corresponding data obtained from [ 11 C]CFT studies in rats. Again, good agreement was obtained between the two methods. Note, only striatal regions were considered in these studies.
Representative parametric images obtained using the basis function approach for [ 11 C]raclopride and [ 11 C]CFT are illustrated in Figs. 6 and 7. The applicability of the simplified reference region model to [ 11 C]SCH 23390 has already been validated at the ROI level . Its application at the voxel level using BFM is illustrated in Fig. 8 . For human data the method takes approximately 1 min per plane (128 ϫ 128 voxels) on a sparc Ultra computer.
The sensitivity of the estimated binding potential in the target tissue to the assumption of no specific binding in the reference tissue was investigated using simulated data as described under Methods. The consequent underestimation of the true binding potential in the target tissue conformed exactly with the theoretical Eq. (6).
DISCUSSION
A method has been presented which allows parametric imaging of both binding potential and the delivery of the ligand relative to the reference region which requires only tomographic tissue data. The principle advantages of the method are robustness and computational speed.
The robustness derives in part from the small number of parameters (3) in the model. However, this formulation involves several major assumptions; a reference region exists and can be defined. Labeled metabolites of the parent tracer do not cross the blood-brain barrier. The degree of nonspecific binding, and the ratio of the rate constants describing the exchange of tracer between plasma and the free/ nonspecific compartment are the same in both tissue and reference regions. The exchange between free and specifically bound compartments is sufficiently fast for their composite behavior to be approximated by a single compartment. Clearly the applicability of these assumptions needs to be taken in account before applying the current method to the analysis of dynamic PET data. In particular attention is drawn to Eq. (6) which describes the sensitivity of the estimates of binding potential to the assumption that the reference tissue is devoid of specific binding. This equation allows for an estimate of the resulting bias if independent data on the specific binding in the reference region is available.
Despite the improvement in stability associated with the reduction in the number of parameters in the reference tissue model from 4 to 3 , additional constraints are required for its implementation at the voxel level. In the present work the robustness of the BFM is achieved by the introduction of parameter bounds in the estimation problem and by the direct search for the global minimum. This is readily enabled by its formulation in terms of basis functions. The parameter bounds are based on a priori knowledge of the ligands' behavior, which can be sensibly obtained from previous ROI analyses. The parameter bounds are particularly important when the method is applied to target regions displaying relatively low binding potential and the shape and scale of the reference and target time activity curves are similar. In this case the estimate of k 2 becomes numerically unidentifiable as can be seen by inspection of Eq. (1). Propagation of this effect to the estimates of BP and R I is minimized by the imposition of parameter bounds.
The introduction of parameter bounds will in general be accompanied by an associated bias. In the examples presented, the bias in the principle parameter of interest, BP, was negligible. However, this property of the method should be investigated in individual applications particularly when the behavior of the ligand approaches irreversibility within the time course of the PET scan.
The computational speed derives from the predefined basis functions being linear in the parameters ( 1 , 2 ). The nonlinear parameter, 3 , is accommodated by a direct search across the basis functions which guarantees a global minimum within the constraints. This approach using linear least squares together with a discretised range of basis functions incorporating the nonlinearity and covering the expected physiological range was introduced by Koeppe et al. (1985) to the quantitation of local cerebral blood flow using a blood input function and the Kety model.
Recently, a method for the estimation of distribution volume ratios using a reference tissue without blood sampling has been proposed by Logan et al. (1996) . This graphical method does not require the assumption of rapid exchange between the compartments in the target tissue but does require an a priori estimate of the efflux rate constant in the reference region (kЈ 2 ) and also the identification of the linear portion of the graph. The present BFM method involves fitting the total untransformed dataset obtained from the target tissue. This requires no arbitrary temporal partitioning of the dataset and facilitates appropriate statistical weighting.
In addition to parametric imaging of BP, the BFM method also allows generation of parametric images of R I and k 2 . The R I images, in particular, provide a useful adjunct to the specific ligand binding images. It would be expected that the R I image would be dominated by relative regional blood flow. In protocols involving repeat scans this provides an independent assessment of any regional changes in delivery. In addition the R I images can be used for coregistration purposes as they provide good structural information. For data such as [ 11 C]raclopride, the specific binding of which is concentrated in the striatum, the transformation parameters derived from R I images can allow for coregistration or stereotactic normalization which can also be applied to the BP images. This will facilitate the statistical analysis at the voxel level of changes in both the delivery and binding of neuroligands.
